Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02036333 · ClinicalTrials.gov registry record
The Role of Cerebral Oximetry in Pediatric Concussion Assessment
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 59
- Enrollment target
NCT02036333: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02036333 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02036333 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a difference in cerebral oxygenation as measured by near-infrared spectroscopy (NIRS) in children with concussion and healthy controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-06-30 |
Why NCT02036333 stopped before completion
NCT02036333 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02036333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02036333 about?
NCT02036333 is a clinical study titled "The Role of Cerebral Oximetry in Pediatric Concussion Assessment". The purpose of this study is to determine whether there is a difference in cerebral oxygenation as measured by near-infrared spectroscopy (NIRS) in children with concussion and healthy controls.
What is the current status of trial NCT02036333?
This trial is currently terminated. The enrollment target is 59 participants. The study started on 2014-01. Estimated completion is 2015-06-30.
Who is sponsoring clinical trial NCT02036333?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia